SCHEMBL2415172

SCHEMBL2415172

COC(=O)C(CCOCc1ccccc1)CC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.45
HTT P42858 2/20 0.45
FOLH1 Q04609 1/20 0.44
MMP3 P08254 4/20 0.44
MMP9 P14780 3/20 0.44
MMP8 P22894 3/20 0.44
CPA1 P15085 2/20 0.44
CPB1 P15086 1/20 0.44
CPA3 P15088 1/20 0.44
CPB2 Q96IY4 1/20 0.44
MMP2 P08253 1/20 0.44
MMP12 P39900 1/20 0.44
ALDH1A1 P00352 2/20 0.42
MMP1 P03956 3/20 0.42
LMNA P02545 2/20 0.42
NPC1 O15118 1/20 0.42
CASP1 P29466 1/20 0.42
LTA4H P09960 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2413866 0.84 PPARA (0.46) KMT2ASMN1; SMN2HTTMMP3MMP9
SCHEMBL2413872 0.84 PPARA (0.46) KMT2ASMN1; SMN2HTTMMP3MMP9
SCHEMBL2413869 0.84 SLC15A1 (0.44) KMT2ASMN1; SMN2HTTFOLH1MMP3
SCHEMBL1405655 0.82 KMT2A (0.53) KMT2ASMN1; SMN2MMP3MMP9CPA1
SCHEMBL9555874 0.82 KMT2A (0.53) KMT2ASMN1; SMN2MMP3MMP9CPA1
SCHEMBL11116485 0.81 SMN1; SMN2 (0.48) KMT2ASMN1; SMN2HTTFOLH1ALDH1A1
SCHEMBL18220621 0.80 SLC1A1 (0.44) KMT2ASMN1; SMN2HTTMMP3MMP9
SCHEMBL735424 0.79 LTA4H (0.55) SMN1; SMN2HTTFOLH1ALDH1A1LMNA
SCHEMBL9574068 0.79 MMP2 (0.57) MMP3MMP2
SCHEMBL12162457 0.79 MMP2 (0.57) MMP3MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2542554-A1 PROCESSES FOR THE PREPARATION OF S1P1 RECEPTOR MODULATORS AND CRYSTALLINE FORMS THEREOF Arena Pharmaceuticals, Inc. (US) 2013-01-09 EP disclosed
WO-2011109471-A1 PROCESSES FOR THE PREPARATION OF S1P1 RECEPTOR MODULATORS AND CRYSTALLINE FORMS THEREOF ARENA PHARMACEUTICALS, INC. (US) 2011-09-09 WO disclosed